KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Twist Bioscience (TWST) Operating Expenses: 2017-2025

Historic Operating Expenses for Twist Bioscience (TWST) over the last 9 years, with Sep 2025 value amounting to $512.8 million.

  • Twist Bioscience's Operating Expenses rose 6.78% to $128.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $512.8 million, marking a year-over-year decrease of 3.93%. This contributed to the annual value of $512.8 million for FY2025, which is 3.93% down from last year.
  • Twist Bioscience's Operating Expenses amounted to $512.8 million in FY2025, which was down 3.93% from $533.8 million recorded in FY2024.
  • Twist Bioscience's Operating Expenses' 5-year high stood at $533.8 million during FY2024, with a 5-year trough of $285.1 million in FY2021.
  • Over the past 3 years, Twist Bioscience's median Operating Expenses value was $512.8 million (recorded in 2025), while the average stood at $503.0 million.
  • In the last 5 years, Twist Bioscience's Operating Expenses surged by 53.77% in 2022 and then declined by 3.93% in 2025.
  • Twist Bioscience's Operating Expenses (Yearly) stood at $285.1 million in 2021, then skyrocketed by 53.77% to $438.3 million in 2022, then climbed by 5.46% to $462.3 million in 2023, then rose by 15.48% to $533.8 million in 2024, then declined by 3.93% to $512.8 million in 2025.